HER-2/neu peptide vaccine [clinicaltrials_resource:f0b9e10fbb0de5316969d8c2b08f802a]
HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer [clinicaltrials:NCT00003002]Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer [clinicaltrials:NCT00005023]HER-2 Protein Vaccine in Treating Women With Breast Cancer [clinicaltrials:NCT00068614]Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer [clinicaltrials:NCT00640861]
intervention [clinicaltrials_vocabulary:intervention]
HER-2/neu peptide vaccine [clinicaltrials_resource:f0b9e10fbb0de5316969d8c2b08f802a]
Bio2RDF identifier
f0b9e10fbb0de5316969d8c2b08f802a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f0b9e10fbb0de5316969d8c2b08f802a
intervention name [clinicaltrials_vocabulary:intervention-name]
HER-2/neu peptide vaccine
identifier
clinicaltrials_resource:f0b9e10fbb0de5316969d8c2b08f802a
title
HER-2/neu peptide vaccine
@en
type
label
HER-2/neu peptide vaccine [clinicaltrials_resource:f0b9e10fbb0de5316969d8c2b08f802a]
@en